The NIHR 'Be Part of Research' service (bepartofresearch.nihr.ac.uk) and ClinicalTrials.gov list currently recruiting studies in the UK and can help you identify suitable trials
doi: 10.1001/jama.2023.19574
External resources NEJM: Triple Hormone-Receptor Agonist Retatrutide for Obesity Phase 2 Trial PMC: Retatrutide - A Game Changer in Obesity Pharmacotherapy PMC: Efficacy and Safety of Retatrutide - Systematic Review and Meta-Analysis American Diabetes Association: Retatrutide Clinical Highlights Nature Medicine: Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease For researchers serious about optimizing their retatrutide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, personalized dosing tools, and a community of thousands who have navigated these exact decisions
As with any medication, individual results can vary
Zubair R, Ishii L, Loyal J, Hartman N, Fabi SG
In the trials, participants who took the highest dose reduced their A1C values by an average of 2.0%